文献速递食管与纵隔外科

胸腺切除术治疗重症肌无力的围术期结局:胸外科数据库分析

Perioperative Outcomes of Thymectomy in Myasthenia Gravis: A Thoracic Surgery Database Analysis.
PubMed 文献 · Ann Thorac Surg · 2021-07-30

基于STS胸外科数据库2009-2019年MG患者胸腺切除术数据,非胸腺瘤病例(n=1725)中VATS、RVATS和TC较TT围术期并发症 odds 更低;胸腺瘤病例(n=311)中TT与微创无显著差异。微创手术比例上升,TT和TC下降。

要点

  • 非胸腺瘤MG中VATS和TC的围术期并发症 odds 低于TT。
  • 胸腺瘤MG中TT与微创(VATS/RVATS)围术期并发症无显著差异。
  • 全国范围内微创胸腺切除术比例增加,即使胸腺瘤切除亦如此。

核心结论

  • 非胸腺瘤性MG患者中,微创和TC胸腺切除术的围术期并发症少于TT胸腺切除术。

研究设计与样本

  • 回顾性分析STS普通胸外科数据库2009-2019年MG患者胸腺切除术病例,按手术方式分为TT、TC、VATS和RVATS,采用多因素logistic回归评估围术期并发症。

主要发现

  • 非胸腺瘤病例(n=1725)中,VATS(OR 0.44;95%CI 0.23-0.83)、RVATS(OR 0.73;95%CI 0.48-1.26)和TC(OR 0.19;95%CI 0.06-0.62)的围术期并发症 odds 低于TT。
  • 非胸腺瘤病例中,VATS(OR 2.29;95%CI 0.63-8.30)和RVATS(OR 4.08;95%CI 1.21-3.78)的围术期并发症 odds 高于TC。
  • 胸腺瘤病例(n=311)中,TT与微创(VATS/RVATS)的围术期并发症 odds 无显著差异。
  • RVATS比例从6.43%增至44.27%,TT从56.43%降至34.35%,TC从19.29%降至6.87%。

临床怎么用

  • 非胸腺瘤性MG患者选择胸腺切除术式时,可考虑微创或TC以降低围术期并发症风险。

局限性

  • 需长期神经学结局数据以确定微创胸腺切除术围术期风险降低是否转化为MG结局改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is clinical equipoise regarding the perioperative and long-term outcomes of autoimmune myasthenia gravis (MG) patients undergoing open vs minimally invasive thymectomy, particularly for nonthymomatous MG. This analysis utilizes multicenter, real-world clinical evidence to assess perioperative complications of open and minimally invasive thymectomy techniques in MG patients. METHODS: Thymectomy cases from 2009 to 2019 in MG patients were identified in The Society of Thoracic Surgeons General Thoracic Surgery Database. Thymectomies were grouped by surgical technique: transthoracic (TT), transcervical (TC), video-assisted thoracoscopic surgery (VATS), or robotic VATS (RVATS). Multivariable logistic regression models assessed the association between surgical technique and perioperative complications. RESULTS: Analysis of nonthymomatous cases (n = 1725) revealed VATS (odds ratio [OR], 0.44; 95% confidence interval [CI], 0.23-0.83), RVATS (OR, 0.73; 95% CI, 0.48-1.26), and TC (OR, 0.19; 95% CI, 0.06-0.62) thymectomies had lower odds of perioperative complications than TT thymectomies. VATS (OR, 2.29; 95% CI, 0.63-8.30) and RVATS (OR, 4.08; 95% CI,1.21-3.78) thymectomies had higher odds of perioperative complications than TC thymectomies. Analysis of thymomatous cases (n = 311) found no significant difference in the odds of perioperative complications in TT vs minimally invasive (VATS/RVATS) procedures. The proportion of RVATS procedures increased from 6.43% to 44.27%, while TT (56.43% to 34.35%) and TC (19.29% to 6.87%) thymectomies decreased. CONCLUSIONS: Minimally invasive and TC thymectomies have fewer perioperative complications than TT thymectomies when performed for nonthymomatous MG. Minimally invasive procedures are increasingly performed for both nonthymomatous and thymomatous disease. There is a nationwide shift toward minimally invasive procedures, even for thymoma resections. Long-term neurological outcome data are needed to determine whether a reduced perioperative risk for minimally invasive thymectomies translates to improved MG outcomes.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Raja SM, Guptill JT, McConnell A, et al. Perioperative Outcomes of Thymectomy in Myasthenia Gravis: A Thoracic Surgery Database Analysis. Ann Thorac Surg. 2021. PMID: 34339670. doi:10.1016/j.athoracsur.2021.06.071

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。